Shandong Sanyuan Biotechnology Co.,Ltd. (SHE:301206)
China flag China · Delayed Price · Currency is CNY
27.01
+0.91 (3.49%)
Apr 29, 2026, 3:04 PM CST

SHE:301206 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
649.51698.51482.71655.821,641
Other Revenue
-14.416.7919.0933.93
649.51712.9499.5674.911,675
Revenue Growth (YoY)
-8.89%42.72%-25.99%-59.71%113.91%
Cost of Revenue
544.82635.4485.47586.98973.9
Gross Profit
104.6977.5114.0387.92701.42
Selling, General & Admin
37.8725.0520.0520.318.8
Research & Development
34.4241.2350.6634.0859
Other Operating Expenses
2.272.882.543.217.01
Operating Expenses
74.5669.873.3157.3485.17
Operating Income
30.137.71-59.2830.58616.26
Interest Expense
-----0
Interest & Investment Income
69.51111.41117.1100.343.5
Currency Exchange Gain (Loss)
-7.452.6842.83-7.47
Other Non Operating Income (Expenses)
5.63-0.25-0.2-0.27-0.73
EBT Excluding Unusual Items
105.27126.3160.31173.48611.55
Gain (Loss) on Sale of Investments
0.37--2.89-0.330.26
Gain (Loss) on Sale of Assets
0.07----0.59
Asset Writedown
-0.27-0.07--0.21-0.01
Other Unusual Items
-1.961.411.028.68
Pretax Income
105.43128.258.82183.96619.9
Income Tax Expense
14.1323.252.8420.2784.48
Earnings From Continuing Operations
91.3104.9555.98163.69535.42
Minority Interest in Earnings
0.11----
Net Income
91.41104.9555.98163.69535.42
Net Income to Common
91.41104.9555.98163.69535.42
Net Income Growth
-12.90%87.47%-65.80%-69.43%130.21%
Shares Outstanding (Basic)
199202200200152
Shares Outstanding (Diluted)
199202200200152
Shares Change (YoY)
-1.54%0.95%0.16%31.61%-0.00%
EPS (Basic)
0.460.520.280.823.53
EPS (Diluted)
0.460.520.280.823.53
EPS Growth
-11.54%85.71%-65.85%-76.77%130.22%
Free Cash Flow
-176.33-155.41-65.68-158.4207.7
Free Cash Flow Per Share
-0.89-0.77-0.33-0.791.37
Dividend Per Share
-1.4000.2500.7000.667
Dividend Growth
-460.00%-64.29%5.00%42.85%
Gross Margin
16.12%10.87%2.81%13.03%41.87%
Operating Margin
4.64%1.08%-11.87%4.53%36.78%
Profit Margin
14.07%14.72%11.21%24.25%31.96%
Free Cash Flow Margin
-27.15%-21.80%-13.15%-23.47%12.40%
EBITDA
103.6673.920.3269.33641.9
EBITDA Margin
15.96%10.37%0.07%10.27%38.31%
D&A For EBITDA
73.5366.2159.6138.7525.65
EBIT
30.137.71-59.2830.58616.26
EBIT Margin
4.64%1.08%-11.87%4.53%36.78%
Effective Tax Rate
13.40%18.14%4.82%11.02%13.63%
Revenue as Reported
-712.9499.5674.911,675
Advertising Expenses
-1.261.170.721.08
Source: S&P Global Market Intelligence. Standard template. Financial Sources.